THE MONITORING DISEASES OF DOG AND CAT ON THE BASE OF THE ZVC "10 DRUZIV" IN SUMY
Abstract
Today, keeping pets is gaining more and more popularity in our country. Under our living conditions, a person needs to take care of someone. Since domestic animals, dogs and cats, are carriers of zoonotic diseases, we must monitor their welfare and health. Factors affecting the health of pets deserve special attention: proper nutrition, maintenance, exercise, timely and high-quality veterinary care. The article presents the results of the assessment of the situation regarding the morbidity of dogs and cats in the city of Sumy on the basis of the "10 Druziv" health center. A statistical analysis of data on the registration of diseases of dogs and cats for the period 2020-2023 was carried out. The research was conducted on the basis of the Department of Virology, Pathanatomy and Poultry Diseases of the Faculty of Veterinary Medicine of the Sumy National Agrarian University and the "10 Druziv" Zoo Veterinary Center. Statistical and clinical research methods were used in their research. We studied the situation regarding the diseases of dogs and cats based on the primary documentation, namely on the logs of registration of the admission of animals to the clinic. Clinical and laboratory diagnostics of dogs and cats were also carried out in order to establish a diagnosis. It was established that during the period 2020-2023, non-communicable diseases prevailed (from 59% to 66%) against contagious diseases (from 21% to 25%). The most common among non-communicable diseases were diseases of the gastrointestinal tract (from 18.9% to 22.9%), urinary system (from 14.9% to 19.9%), cardiovascular system (from 12.9% to 14 .9%) and dermatological diseases (from 10.9% to 12.9%). Congenital pathologies of the cardiovascular system were not widespread and only 9 cases were registered in three years. Taking into account the statistical data, diseases of the cardiovascular system are relevant for further research, as they showed a tendency to increase in the period 2020-2023. Among the pathologies of the cardiovascular system of dogs and cats, the overwhelming majority was related to diseases of the endocardium, namely mitral valve endocardiosis (41.63-48.47%). The development of effective protocols for the treatment of dogs and cats with cardiovascular diseases is a promising direction in veterinary medicine.
References
2. Borgarelli, M., Savarino, P., Crosara, S., Santilli, R. A., Chiavegato, D., Poggi, M., ... & Tarducci, A. (2008). Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. Journal of veterinary internal medicine, 22(1), 120-128.
3. Boswood, A., Häggström, J., Gordon, S. G., Wess, G., Stepien, R. L., Oyama, M. A., Keene, B. W., Bonagura, J., MacDonald, K. A., Patteson, M., Smith, S., Fox, P. R., Sanderson, K., Woolley, R., Szatmári, V., Menaut, P., Church, W. M., O'Sullivan, M. L., Jaudon, J. P., Kresken, J. G., … Watson, P. (2016). Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial. Journal of veterinary internal medicine, 30(6), 1765–1779. https://doi.org/10.1111/jvim.14586
4. Casey, R. A., & Bradshaw, J. W. (2008). Owner compliance and clinical outcome measures for domestic cats undergoing clinical behavior therapy. Journal of veterinary behavior, 3(3), 114-124.
5. Chen, D. L. (2018). Bachelor’s thesis. National University of Defense Technology.
6. Cunningham, S. M., Rush, J. E., & Freeman, L. M. (2012). Systemic inflammation and endothelial dysfunction in dogs with congestive heart failure. Journal of veterinary internal medicine, 26(3), 547–557. https://doi.org/10.1111/j.1939-1676.2012.00923.x
7. Desai MY, Bhonsale A, Smedira NG, Naji P, Thamilarasan M, Lytle BW, Lever HM. Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction. Circulation. 2013 Jul 16;128(3):209-16. doi: 10.1161/CIRCULATIONAHA.112.000849. Epub 2013 Jun 14. PMID: 23770748.
8. Fox P. R. (2012). Pathology of myxomatous mitral valve disease in the dog. Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 14(1), 103–126. https://doi.org/10.1016/j.jvc.2012.02.001
9. Garncarz, M., Parzeniecka-Jaworska, M., & Szaluś-Jordanow, O. (2017). Congenital heart defects in dogs: A retrospective study of 301 dogs. Med Weter, 73(10), 651-656.
10. Herman, E., & Eldridge, S. (2019). Spontaneously occurring cardiovascular lesions in commonly used laboratory animals. Cardio-oncology (London, England), 5, 6. https://doi.org/10.1186/s40959-019-0040-y1
11. Inoue, M., Hasegawa, A., & Sugiura, K. (2016). Morbidity pattern by age, sex and breed in insured cats in Japan (2008-2013). Journal of feline medicine and surgery, 18(12), 1013–1022. https://doi.org/10.1177/1098612X15616433
12. Jaffey J.A., Wiggen K., Leach S.B., Masseau I., Girens R.E., Reinero C.R. (2019). Pulmonary hypertension secondary to respiratory disease and/or hypoxia in dogs: Clinical features, diagnostic testing and survival, The Veterinary Journal, 251, 105347, ISSN 1090-0233 https://doi.org/10.1016/j.tvjl.2019.105347
13. Johnson, L. R., & Stern, J. A. (2020). Clinical features and outcome in 25 dogs with respiratory-associated pulmonary hypertension treated with sildenafil. Journal of veterinary internal medicine, 34(1), 65–73. https://doi.org/10.1111/jvim.15679
14. Keene, B. W., Atkins, C. E., Bonagura, J. D., Fox, P. R., Häggström, J., Fuentes, V. L., Oyama, M. A., Rush, J. E., Stepien, R., & Uechi, M. (2019). ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. Journal of veterinary internal medicine, 33(3), 1127–1140. https://doi.org/10.1111/jvim.15488
15. Khan, S., Joyce, J., Margulies, K. B., & Tsuda, T. (2014). Enhanced bioactive myocardial transforming growth factor-β in advanced human heart failure. Circulation journal : official journal of the Japanese Circulation Society, 78(11), 2711–2718. https://doi.org/10.1253/circj.cj-14-0511
16. Lancellotti, P., Tribouilloy, C., Hagendorff, A., Popescu, B. A., Edvardsen, T., Pierard, L. A., Badano, L., Zamorano, J. L., & Scientific Document Committee of the European Association of Cardiovascular Imaging (2013). Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. European heart journal. Cardiovascular Imaging, 14(7), 611–644. https://doi.org/10.1093/ehjci/jet105
17. Locatelli, C., Spalla, I., Domenech, O., Sala, E., Brambilla, P. G., & Bussadori, C. (2013). Pulmonic stenosis in dogs: survival and risk factors in a retrospective cohort of patients. The Journal of small animal practice, 54(9), 445–452. https://doi.org/10.1111/jsap.12113
18. Maron, B. J., & Fox, P. R. (2015). Hypertrophic cardiomyopathy in man and cats. Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 17 Suppl 1, S6–S9. https://doi.org/10.1016/j.jvc.2015.03.007
19. März, I., Wilkie, L. J., Harrington, N., Payne, J. R., Muzzi, R. A., Häggström, J., Smith, K., & Luis Fuentes, V. (2015). Familial cardiomyopathy in Norwegian Forest cats. Journal of feline medicine and surgery, 17(8), 681–691. https://doi.org/10.1177/1098612X14553686
20. Oliveira, P., Domenech, O., Silva, J., Vannini, S., Bussadori, R., & Bussadori, C. (2011). Retrospective review of congenital heart disease in 976 dogs. Journal of veterinary internal medicine, 25(3), 477–483. https://doi.org/10.1111/j.1939-1676.2011.0711.x
21. Olsen, L. H., Mortensen, K., Martinussen, T., Larsson, L. I., Baandrup, U., & Pedersen, H. D. (2003). Increased NADPH-diaphorase activity in canine myxomatous mitral valve leaflets. Journal of comparative pathology, 129(2-3), 120–130. https://doi.org/10.1016/s0021-9975(03)00019-7
22. Paige, C. F., Abbott, J. A., Elvinger, F., & Pyle, R. L. (2009). Prevalence of cardiomyopathy in apparently healthy cats. Journal of the American Veterinary Medical Association, 234(11), 1398–1403. https://doi.org/10.2460/javma.234.11.1398
23. Rao, V. V., Nagaraju, P., & Kumari, K. N. (2008). Echocardiographic evaluation of congestive heart failure in dogs. Intas polivet, 9(2), 199-201.
24. Reinero, C., Visser, L. C., Kellihan, H. B., Masseau, I., Rozanski, E., Clercx, C., Williams, K., Abbott, J., Borgarelli, M., & Scansen, B. A. (2020). ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs. Journal of veterinary internal medicine, 34(2), 549–573. https://doi.org/10.1111/jvim.15725
25. Rippe, J., Fishbein, M. C., Carabello, B., Angoff, G., Sloss, L., Collins, J. J., Jr, & Alpert, J. S. (1980). Primary myxomatous degeneration of cardiac valves. Clinical, pathological, haemodynamic, and echocardiographic profile. British heart journal, 44(6), 621–629. https://doi.org/10.1136/hrt.44.6.621
26. Rishniw M, Pion PD. Is treatment of feline hypertrophic cardiomyopathy based in science or faith? A survey of cardiologists and a literature search. J Feline Med Surg. 2011 Jul;13(7):487-97. doi: 10.1016/j.jfms.2011.05.006. PMID: 21704898
27. Schober, K. E., Zientek, J., Li, X., Fuentes, V. L., & Bonagura, J. D. (2013). Effect of treatment with atenolol on 5-year survival in cats with preclinical (asymptomatic) hypertrophic cardiomyopathy. Journal of veterinary cardiology: the official journal of the European Society of Veterinary Cardiology, 15(2), 93–104. https://doi.org/10.1016/j.jvc.2013.03.003
28. Schrope D. P. (2015). Prevalence of congenital heart disease in 76,301 mixed-breed dogs and 57,025 mixed-breed cats. Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 17(3), 192–202. https://doi.org/10.1016/j.jvc.2015.06.001
29. Simpson, S., Rutland, P., & Rutland, C. S. (2017). Genomic Insights into Cardiomyopathies: A Comparative Cross-Species Review. Veterinary sciences, 4(1), 19. https://doi.org/10.3390/vetsci4010019
30. Summerfield, N. J., Boswood, A., O'Grady, M. R., Gordon, S. G., Dukes-McEwan, J., Oyama, M. A., Smith, S., Patteson, M., French, A. T., Culshaw, G. J., Braz-Ruivo, L., Estrada, A., O'Sullivan, M. L., Loureiro, J., Willis, R., & Watson, P. (2012). Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT Study). Journal of veterinary internal medicine, 26(6), 1337–1349. https://doi.org/10.1111/j.1939-1676.2012.01026.x
ISSN 
ISSN 
